Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Assets Average (2011 - 2026)

Skinvisible's (SKVI) quarterly Assets Average came in at $121376.5 in Q2 2026, down 17.13% year-over-year from $146464.5 in Q2 2025, and down 1.71% quarter-over-quarter from $123493.0 in Q1 2026.

Analysis

Skinvisible (SKVI) Assets Average (2011 - 2026) Analysis & Trends

Skinvisible has disclosed Assets Average across 16 years of filings, most recently posting $121376.5 for Q2 2026.

  • In Q2 2026, Assets Average fell 17.13% year-over-year to $121376.5; the TTM figure through Jun 2026 stood at $121376.5 (down 17.13% YoY), while the FY2025 annual figure was $142892.0, down 10.99% from the prior year.
  • Assets Average came in at $121376.5 for Q2 2026 at Skinvisible, down from $123493.0 in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $299874.0 in Q3 2022 to a low of $121376.5 in Q2 2026.
  • Average Assets Average over 5 years is $180689.5, with a median of $158183.2 recorded in 2024.
  • Year-over-year, Assets Average surged 34.3% in 2022 and slumped 36.41% in 2023.
  • Over 5 years, Assets Average stood at $262975.5 in 2022, then tumbled by 33.85% to $173965.0 in 2023, then declined by 11.8% to $153430.0 in 2024, then dropped by 14.88% to $130595.0 in 2025, then retreated by 7.06% to $121376.5 in 2026.
  • Per Business Quant data, the three most recent Assets Average figures were $121376.5 in Q2 2026, $123493.0 in Q1 2026, and $130595.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Johnson & Johnson 647.06 Bn 626.30 Bn 17.26 Bn 200.98 Bn
2 AbbVie 440.06 Bn 433.49 Bn 12.70 Bn 135.79 Bn
3 Merck 364.19 Bn 357.05 Bn 12.21 Bn 129.24 Bn
4 Novartis Ag 268.45 Bn 260.76 Bn 11.24 Bn 120.28 Bn
5 Pfizer 158.40 Bn 146.70 Bn 10.94 Bn 204.57 Bn
6 Sanofi 52.57 Bn 45.19 Bn 10.79 Bn 149.95 Bn
7 Revolution Medicines 44.32 Bn 44.32 Bn - 3.29 Bn
8 Incyte 24.98 Bn 20.44 Bn 1.57 Bn 7.61 Bn
9 United Therapeutics 21.15 Bn 18.49 Bn 683.80 Mn 6.97 Bn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00 121,376.50
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121,376.50
Mar 31, 2026 123,493.00
Dec 31, 2025 130,595.00
Sep 30, 2025 138,499.00
Jun 30, 2025 146,464.50
Mar 31, 2025 153,885.50
Dec 31, 2024 153,430.00
Sep 30, 2024 155,850.50
Jun 30, 2024 158,230.50
Mar 31, 2024 158,136.00
Dec 31, 2023 173,965.00
Sep 30, 2023 190,690.00
Jun 30, 2023 201,088.50
Mar 31, 2023 226,325.50
Dec 31, 2022 262,975.50
Sep 30, 2022 299,874.00
Jun 30, 2022 252,089.00
Mar 31, 2022 205,443.50
Dec 31, 2021 221,535.00
Sep 30, 2021 223,284.50